Can exhaled inflammatory markers predict a steroid response in wheezing preschool children?

Clinical and Experimental Allergy

Volumn 41, Issue 8, 2011, Pages 1076-1083

  van de Kant, K D G ^a   Koers, K ^a   Rijkers, G T ^b,c   Lima Passos, V ^a   Klaassen, E M M ^a   Mommers, M ^a   Dagnelie, P C ^a   van Schayck, C P ^a   Dompeling, E ^a   Jobsis Q ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Airway inflammation; Chemokines; Cytokines; EBC; Infants; Inhaled corticosteroids; Nitric oxide; Wheeze

Indexed keywords

BECLOMETASONE; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE;

AIRWAY RESISTANCE; ARTICLE; ATOPY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; EXHALATION; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATION; MALE; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; RESPIRATORY SOUNDS;

EID: 79960419815     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03774.x     Document Type: Article

References (30)

1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133-8.
2. Henderson J, Granell R, Sterne J. The search for new asthma phenotypes. Arch Dis Child 2009; 94:333-6.
3. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009; 123:e519-25.
4. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354:1998-2005.
5. Bacharier LB, Phillips BR, Zeiger RS et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008; 122:1127-35.
6. McDougall CM, Helms PJ. Neutrophil airway inflammation in childhood asthma. Thorax 2006; 61:739-41.
7. van de Kant KD, Klaassen EM, Jöbsis Q. et al. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. J Allergy Clin Immunol 2010; 126:669-71.
8. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351:225-32.
9. van de Kant KD, Klaassen EM, Jöbsis Q, Nijhuis AJ, van Schayck OC, Dompeling E. Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study. BMC Public Health 2009; 9:210.
10. Powell CV, McNamara P, Solis A, Shaw NJ. A parent completed questionnaire to describe the patterns of wheezing and other respiratory symptoms in infants and preschool children. Arch Dis Child 2002; 87:376-9.
11. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 2000; 162:1500-6.
12. Rosias PP, Robroeks CM, van de Kant KD. et al. Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol 2010; 21:e235-44.
13. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10:133-9.
14. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981; 2:93-113.
15. Little SA, Chalmers GW, MacLeod KJ, McSharry C, Thomson NC. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55:232-4.
16. Smith AD, Cowan JO, Brassett KP et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005; 172:453-9.
17. Meijer RJ, Postma DS, Kauffman HF, Arends LR, Koeter GH, Kerstjens HA. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exp Allergy 2002; 32:1096-103.
18. Ducharme FM, Lemire C, Noya FJ. et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009; 360:339-53.
19. Oh JW, Seroogy CM, Meyer EH et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002; 110:460-8.
20. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005; 5:271-83.
21. Szefler SJ, Phillips BR, Martinez FD. et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115:233-42.
22. Zacharasiewicz A, Wilson N, Lex C et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171:1077-82.
23. Martin RJ, Szefler SJ, King TS. et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119:73-80.
24. Zielen S, Christmann M, Kloska M. et al. Predicting short term response to anti-inflammatory therapy in young children with asthma. Curr Med Res Opin 2010; 26:483-92.
25. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-30.
26. Matsunaga K, Ichikawa T, Yanagisawa S. Clinical application of exhaled breath condensate analysis in asthma: prediction of FEV(1) improvement by steroid therapy. Respiration 2009; 78:393-8.
27. Robroeks CM, van de Kant KD, van Vliet D. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. Ann Allergy Asthma Immunol 2008; 100:601-7.
28. Vogelberg C, Wurfel C, Knoetzsch A, Kahlert A, Range U, Leupold W. Exhaled breath condensate pH in infants and children with acute and recurrent wheezy bronchitis. Pediatr Pulmonol 2007; 42:1166-72.
29. Pijnenburg MW, De Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy 2008; 38:246-59.
30. Horvath I, Hunt J, Barnes PJ et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523-48.